120 related articles for article (PubMed ID: 3286047)
1. Angiotensin and the renal circulation in hypertension.
Hollenberg NK; Williams GH
Circulation; 1988 Jun; 77(6 Pt 2):I59-63. PubMed ID: 3286047
[TBL] [Abstract][Full Text] [Related]
2. Sodium sensitive hypertension: renal and adrenal non-modulation in its pathogenesis.
Hollenberg NK; Williams GH
Kidney; 1988 Nov; 21(3):13-8. PubMed ID: 11538850
[TBL] [Abstract][Full Text] [Related]
3. The state and responsiveness of the renin-angiotensin-aldosterone system in patients with type II diabetes mellitus.
Price DA; De'Oliveira JM; Fisher ND; Williams GH; Hollenberg NK
Am J Hypertens; 1999 Apr; 12(4 Pt 1):348-55. PubMed ID: 10232494
[TBL] [Abstract][Full Text] [Related]
4. Correction of abnormal renal blood flow response to angiotensin II by converting enzyme inhibition in essential hypertensives.
Redgrave J; Rabinowe S; Hollenberg NK; Williams GH
J Clin Invest; 1985 Apr; 75(4):1285-90. PubMed ID: 2985655
[TBL] [Abstract][Full Text] [Related]
5. Angiotensinogen genotype predicts abnormal renal hemodynamics in young hypertensive patients.
Patel TV; Williams GH; Fisher ND
J Hypertens; 2008 Jul; 26(7):1353-9. PubMed ID: 18551010
[TBL] [Abstract][Full Text] [Related]
6. Different reactivity to angiotensin II of peripheral and renal arteries in spontaneously hypertensive rats: effect of acute and chronic angiotensin converting enzyme inhibition.
Guidi E; Hollenberg NK
J Hypertens Suppl; 1986 Dec; 4(6):S480-2. PubMed ID: 11538668
[TBL] [Abstract][Full Text] [Related]
7. Renal abnormalities in nonmodulating essential hypertension.
Williams GH; Moore TJ; Hollenberg NK
Am J Kidney Dis; 1987 Jul; 10(1 Suppl 1):39-44. PubMed ID: 3037888
[TBL] [Abstract][Full Text] [Related]
8. Converting enzyme inhibition: implications for renal perfusion and function.
Hollenberg NK
Clin Exp Pharmacol Physiol Suppl; 1982; 7():73-9. PubMed ID: 6183037
[TBL] [Abstract][Full Text] [Related]
9. Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.
Fisher ND; Jan Danser AH; Nussberger J; Dole WP; Hollenberg NK
Circulation; 2008 Jun; 117(25):3199-205. PubMed ID: 18559696
[TBL] [Abstract][Full Text] [Related]
10. Renal effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibition in healthy subjects.
Burnier M; Brunner HR
Exp Nephrol; 1996; 4 Suppl 1():41-6. PubMed ID: 9001896
[TBL] [Abstract][Full Text] [Related]
11. Renal response to angiotensin II is blunted in sodium-sensitive normotensive men.
Visser FW; Boonstra AH; Titia Lely A; Boomsma F; Navis G
Am J Hypertens; 2008 Mar; 21(3):323-8. PubMed ID: 18219299
[TBL] [Abstract][Full Text] [Related]
12. Converting enzyme inhibition to identify and treat renin-mediated or sodium-volume related forms of increased peripheral resistance in hypertension and in congestive heart failure.
Cody RJ; Laragh JH; Atlas SA; Case DB
J Hypertens Suppl; 1983 Oct; 1(1):77-84. PubMed ID: 6085835
[TBL] [Abstract][Full Text] [Related]
13. Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease.
Jensen J; Henik RA; Brownfield M; Armstrong J
Am J Vet Res; 1997 May; 58(5):535-40. PubMed ID: 9140564
[TBL] [Abstract][Full Text] [Related]
14. Renal mechanisms of angiotensin II-induced hypertension.
Granger JP; Schnackenberg CG
Semin Nephrol; 2000 Sep; 20(5):417-25. PubMed ID: 11022893
[TBL] [Abstract][Full Text] [Related]
15. Converting enzyme inhibitors normalize the reduced adrenal responsiveness to angiotensin II in essential hypertension.
Williams GH; Hollenberg NK
J Hypertens Suppl; 1984 Dec; 2(2):S43-7. PubMed ID: 6100876
[TBL] [Abstract][Full Text] [Related]
16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
Bauer JH; Reams GP
J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic interruption of the renin-angiotensin system and the kidney: differential responses to angiotensin-converting enzyme and renin inhibition.
Hollenberg NK
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S239-42. PubMed ID: 9892171
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of action of enalapril in experimental hypertension and acute left ventricular failure.
Sweet CS; Gaul SL; Reitz PM; Blaine EH; Ribeiro LT
J Hypertens Suppl; 1983 Oct; 1(1):53-63. PubMed ID: 6100609
[TBL] [Abstract][Full Text] [Related]
19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
20. [Inhibition of the angiotensin-converting enzyme--effect on kidney function and electrolyte balance].
Kramer HJ
Z Kardiol; 1988; 77 Suppl 3():39-45. PubMed ID: 3062959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
